logo
Cassava Sciences chief medical officer James Kupiec to retire

Cassava Sciences chief medical officer James Kupiec to retire

Cassava Sciences (SAVA) announced the retirement of James Kupiec, chief medical officer, effective May 9. The company also appointed Jack Moore as senior VP, clinical development, reporting to Rick Barry, CEO.
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wells Fargo Keeps Their Buy Rating on TransUnion (TRU)
Wells Fargo Keeps Their Buy Rating on TransUnion (TRU)

Business Insider

time21 minutes ago

  • Business Insider

Wells Fargo Keeps Their Buy Rating on TransUnion (TRU)

Wells Fargo analyst Jason Haas CFA maintained a Buy rating on TransUnion yesterday and set a price target of $118.00. The company's shares closed yesterday at $99.22. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Haas CFA is ranked #749 out of 9862 analysts. In addition to Wells Fargo, TransUnion also received a Buy from BMO Capital's Ryan Griffin CFA in a report issued yesterday. However, on the same day, Goldman Sachs maintained a Hold rating on TransUnion (NYSE: TRU). Based on TransUnion's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $1.14 billion and a net profit of $287.8 million. In comparison, last year the company earned a revenue of $1.04 billion and had a net profit of $85 million

Goldman Sachs Remains a Buy on Nestlé SA (NSRGF)
Goldman Sachs Remains a Buy on Nestlé SA (NSRGF)

Business Insider

time36 minutes ago

  • Business Insider

Goldman Sachs Remains a Buy on Nestlé SA (NSRGF)

In a report released yesterday, Olivier Nicolai from Goldman Sachs reiterated a Buy rating on Nestlé SA, with a price target of CHF92.00. The company's shares closed yesterday at $90.99. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nicolai covers the Consumer Defensive sector, focusing on stocks such as Nestlé SA, Reckitt, and Diageo. According to TipRanks, Nicolai has an average return of 3.9% and a 53.89% success rate on recommended stocks. In addition to Goldman Sachs, Nestlé SA also received a Buy from DZ BANK AG's Axel Herlinghaus in a report issued on July 24. However, yesterday, Barclays maintained a Hold rating on Nestlé SA (Other OTC: NSRGF). Based on Nestlé SA's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $46.49 billion and a net profit of $5.24 billion. In comparison, last year the company earned a revenue of $46.71 billion and had a net profit of $5.56 billion Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NSRGF in relation to earlier this year.

Centene (CNC) Gets a Hold from TD Cowen
Centene (CNC) Gets a Hold from TD Cowen

Business Insider

time36 minutes ago

  • Business Insider

Centene (CNC) Gets a Hold from TD Cowen

TD Cowen analyst Ryan Langston maintained a Hold rating on Centene yesterday and set a price target of $33.00. The company's shares closed yesterday at $28.39. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Langston is an analyst with an average return of -20.1% and a 17.07% success rate. Langston covers the Healthcare sector, focusing on stocks such as Centene, UnitedHealth, and Humana. In addition to TD Cowen, Centene also received a Hold from Robert W. Baird's Michael Ha in a report issued yesterday. However, on the same day, TR | OpenAI – 4o reiterated a Buy rating on Centene (NYSE: CNC). CNC market cap is currently $13.32B and has a P/E ratio of 3.98.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store